Drug Name |
Alendronate sodium |
Drug ID |
BADD_D00065 |
Description |
Alendronic acid is a second generation bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease[FDA Label][A959,A203111]. It functions by preventing resorption of bone[FDA Label][A959]. |
Indications and Usage |
For the treatment and prevention of osteoporosis in women and Paget's disease of bone in both men and women. |
Marketing Status |
Prescription; Discontinued |
ATC Code |
M05BA04 |
DrugBank ID |
DB00630
|
KEGG ID |
D00939
|
MeSH ID |
D019386
|
PubChem ID |
6331783
|
TTD Drug ID |
D09KLR
|
NDC Product Code |
53104-7525; 50090-4692; 76282-682; 69543-130; 63629-7329; 50090-4076; 61919-689; 16714-633; 65862-329; 60429-055; 64980-340; 60723-205; 61919-729; 65862-268; 65862-328; 55111-874; 64980-342; 0115-1680; 69097-224; 60723-207; 65691-0056; 69097-223; 68071-1514; 50090-5677; 50090-2322; 0115-1678; 0115-1676; 70518-0033; 51224-301; 0054-0282; 78206-135; 71205-048; 0115-1679; 68788-7130; 50090-3593; 0115-1681; 50090-3126; 60429-056; 65862-327; 63415-0071; 16714-631; 68071-3171; 50090-5474; 65372-1134; 64980-341; 76282-681; 68071-3340; 68071-4017; 69543-131; 17139-400; 13371-111; 16714-632 |
Synonyms |
Alendronate | 4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate | Aminohydroxybutane Bisphosphonate | MK-217 | MK 217 | MK217 | Alendronate Monosodium Salt, Trihydrate | Alendronate Sodium | Fosamax |